David Shurtleff, Ph.D., has provided leadership at the National Institute on Drug Abuse (NIDA) and at the National Center for Complementary and Integrative Health (NCCIH) during his 19 year career at the National Institutes of Health (NIH). He has managed an extensive portfolio in cutting-edge behavioral research and neuroscience related to drug abuse, addiction, and their treatment. In his current position, he is fostering research on complementary and integrative approaches for the treatment of pain and other disorders. His honors include two NIH Director’s Awards; one for outstanding leadership, dedication, and oversight in developing the NIH Blueprint Neurotherapeutics Grand Challenge, and the other for outstanding contributions to the development and advancement of diverse programs in basic neuroscience and behavioral research.
Dr. Shurtleff began his NIH career at NIDA as a health scientist administrator in the Behavioral Sciences Research Branch. From 2001-2011, Dr. Shurtleff served as the Director of NIDA’s Division of Basic Neuroscience and Behavioral Research, and in January, 2011 was appointed Acting Deputy Director of NIDA. In this position, he oversaw NIDA’s programs including a diverse grants and contracts portfolio covering basic cellular, molecular, and systems neurobiology, behavioral and treatment research, medications development, clinical neuroscience, clinical trials, prevention, and health services research. He also served as Acting Director of NIDA’s Office of Special Populations for two years where he promoted health disparities research and helped to increase diversity in the biomedical and behavioral science workforce. Since 2000, Dr. Shurtleff has been sharing his expertise with early career investigators who have attended the NIDA/ CPDD Grant Writing Workshop. Currently, Dr. Shurtleff serves as the Deputy Director of NCCIH.